The IMPACTS-BP trial showed that SPRINT-like reductions in systolic BP are possible even in tough real-world scenarios.

Among patients with a single CTO lesion, the study found an improvement in health status compared with medical therapy.

The benefit of digoxin was driven by reduced risk of new-onset or worsening HF hospitalizations, just like its benefit in ...

Kenneth Rosenfield, Erik Klok, and Stavros Konstantinides join Mamas Mamas to discuss ultrasound-facilitated, ...

Helping patients get groceries and make meals while staying on a DASH-approved diet not only helped, but people liked it, too ...

The results, which are mostly relevant to an older population, address a common dilemma for aortic stenosis patients with CAD ...

Low-income patients receiving a debit card spent most of the money on things upstream of medical care like food and utilities ...

The lack of effect on different measures of coronary plaque reinforce the need for a large CV outcomes trial in these ...

The results run counter to ABYSS but align with other data showing beta-blockers shouldn’t continue indefinitely after MI.

The consistent underrepresentation of African populations in clinical studies is a ‘crisis of scientific validity,’ Bamba ...

Ami Bhatt discusses the effort to build an infrastructure and guardrails for AI and how clinicians can take part.

Robert Yeh talks with host Yael L. Maxwell about forging new paths in cardiovascular research and learning how to turn down ...